Category Archives: Cell Therapy

Stem cell therapy treats animal ailments, vets see improvement
Stem cell therapy is typically tied to controversy but now, some Southern Arizona veterinarians are turning to a different form of the cutting edge treatment...

By: kgun9

Go here to see the original:
Stem cell therapy treats animal ailments, vets see improvement - Video

HUMAN nature has it that when there is something new, be it related to food, enhancements to ones appearance, and even in ones search for answers and treatments to an illness, one may be most willing to brave and enter that unknown territory.

I had the privilege of meeting a very remarkable woman, diagnosed with the Big C of the liver, who, in her desire to prolong her days, agreed to go through stem cell therapy.

In the course of our conversation, I realized that, patients must be given the correct information, and should be armed with the necessary knowledge of the treatment modalities, including success and failure rates, complications, cost and expectations.

This applies not only to what is new, but, even in the most tested of treatment options, patients have the right to know and understand.

Stem cell therapy is one breakthrough in Medical Science. It shows a lot of promise and potential in treating diseases. Stem cell therapy is an intervention strategy where new adult stem cells are introduced into damaged or diseased tissues, in order to treat the disease or injury.

These cells are present during the early stages of life and have the remarkable potential to develop into many different types of cells, and in many tissues, they serve as an internal repair system: they divide to replace and replenish cells that have been diseased.

Research directed to the benefits and usefulness of stem cells, when introduced to a given person with a given injury or illness like the Big C, Diabetes, baldness, leukemia, to name a few, has given rise to clinics and centers offering such services. There are just a few facts that I would like to touch before we get too excited to try it out:

Our body use different types of tissue-specific stem cells to fit a particular purpose. The bone marrow for example has the capacity to regenerate the blood cells.

Stem cells directed to the brain or the pancreas or liver or any organ for that matter must be specific to that organ in order for it to become effective. It is very unlikely then to think that one needs JUST A SINGLE CELL TYPE to treat a multitude of unrelated diseases that involve different tissues or organs.

Once we understand this basic principle of how the stem cells work in the body, we are freed from the incorrect idea that stem cell therapy is a CURE ALL treatment modality.

Read the original here:
Understanding the basics of stem cell therapy (First Part)

By: Jet Villa, InterAksyon.com August 20, 2013 3:45 PM

InterAksyon.com The online news portal of TV5

MANILA, Philippines Reminder for those who wish to have their stem cell therapy practice and products accredited: You have until August 31 to register, the Department of Health said Tuesday.

Citing Administrative Order 2013-0012 issued March 18 this year, Health Secretary Enrique Ona said that while the Department of Health (DOH) supports scientific advancement in the field of cellular medicine, its priority is to protect the public from harm rather than give a blanket endorsement of its use or potential benefits.

Those who need to seek accreditation include: health care facilities doing stem cell therapy (with the DOH) as well as companies that import, market, and produce stem cell products (with the Food and Drug Administration, which is under DOH).

Ona said the DOH seeks to regulate stem cell therapy both as a recognized treatment modality and for research purposes.

"This is to allay fears that unscrupulous individuals or groups will engage in unethical practices and subject naive patients to undue harm and unproven medical claims," he added.

Among the DOH guidelines are:

Ona conceded that there are only a limited number of medical conditions in which stem cell therapy may be indicated.

Others are claims that should be taken with a grain of salt, he said.

Read more:
REMINDER | Stem-cell therapy accreditation deadline is Aug. 31 - DOH

By: Jet Villa, InterAksyon.com August 20, 2013 3:45 PM

InterAksyon.com The online news portal of TV5

MANILA, Philippines Reminder for those who wish to have their stem cell therapy practice and products accredited: You have until August 31 to register, the Department of Health said Tuesday.

Citing Administrative Order 2013-0012 issued March 18 this year, Health Secretary Enrique Ona said that while the Department of Health (DOH) supports scientific advancement in the field of cellular medicine, its priority is to protect the public from harm rather than give a blanket endorsement of its use or potential benefits.

Those who need to seek accreditation include: health care facilities doing stem cell therapy (with the DOH) as well as companies that import, market, and produce stem cell products (with the Food and Drug Administration, which is under DOH).

Ona said the DOH seeks to regulate stem cell therapy both as a recognized treatment modality and for research purposes.

"This is to allay fears that unscrupulous individuals or groups will engage in unethical practices and subject naive patients to undue harm and unproven medical claims," he added.

Among the DOH guidelines are:

Ona conceded that there are only a limited number of medical conditions in which stem cell therapy may be indicated.

Others are claims that should be taken with a grain of salt, he said.

Read more:
REMINDER | Stem-cell therapy accreditation deadline is Aug. 31 - DOH

CHEYENNE, WY- (ACCESSWIRE - August 20,2013) - Therapy Cells Inc (OTC Pink: TCEL) announces that on 13 February 2013, US patent US 11/702,895 was awarded to renowned scientist Dr Patrick Casey and Transplantation Ltd, for his transformational cell therapy, exclusively licensed to Therapy Cells Inc for use in human applications.

This revolutionary science dispenses with the traditional notion that cells cannot divide once they are fully mature. Dr Casey has shown that adult cells, given the right environment, can in fact divide and be grown in the laboratory. These new cells can then be used for transportation back to damaged tissue in the body, to enact tissue and organ healing.

The research team headed by Dr Casey has to date treated more than 80 horses including thoroughbreds, standardbreds, polo ponies and horses at the highest level of equestrian competition.

"With a growing level of trial success in horses, Therapy Cells' target is to gain FDA approval, and in short order have human applications in human tendons," Dr Casey says. "An initial valuation of $30 million USD for our science and technology has been appraised. FDA approval for clinical use of this technology in humans, will likely increase this factor by at least 10 times." The horse is an FDA approved model species for athletic injuries.

Dr Casey is a Veterinary graduate from Massey University (BVSc, 1988), and graduate from the University of California in 1992 with a Doctor of Philosophy (PhD, Comparative Pathology). During his time in the United States he also completed an Equine Surgical Internship at Hagyard-Davidson and McGee, Lexington, Kentucky, followed by a three year residency programme in Equine Reproduction, with a minor in Equine Medicine at UC Davis. In 1992, 1993, and 1994 he received a post-doctoral fellowship from the Equine Research Laboratory at the University of California, which allowed him to set up with the late, world renowned, Professor Liggins at the University of Auckland, New Zealand.

Since 2011, Dr Casey has been chief scientific consultant to a public company in the USA - Therapy Cells Inc (TCEL on the OTC Market).

This exciting Bio Tech/Med tech Company holds the exclusive technology that allows adult cells from a specific tissue (e.g. Achilles tendon) to grow again from an individual to enact repair and regeneration of that tissue, effectively by-passing the need for Stem Cell treatment.

"The financial and curative potential of this biotechnology platform is immediately obvious," states Dr Casey. "When we talk about regenerative procedures, the ability to rejuvenate tissues and organs with cultivated natural cell therapy, it's easy to understand how enormous the opportunity and the impact will be. The awarding of this US Patent for our transformational science is a significant milestone in the steps we have been taking to get our therapies to market."

Contact:

Contact: Patrick Casey

Read more:
Therapy Cells, Inc Receives USA Patent Granted for Revolutionary Cell Therapy